World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02053857
Date of registration: 31/01/2014
Prospective Registration: Yes
Primary sponsor: Washington University School of Medicine
Public title: Pilot Study of PUFA-optimized RUTF for Severe Acute Malnutrition
Scientific title: A Randomized, Double-blind Pilot Study of Polyunsaturated Fatty Acid-optimized Ready-to-use Therapeutic Food, Compared to Standard RUTF, in the Therapy of Severe Acute Malnutrition
Date of first enrolment: February 2014
Target sample size: 141
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02053857
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Malawi
Contacts
Name:     Mark J Manary, MD
Address: 
Telephone:
Email:
Affiliation:  Washington University School of Medicine
Name:     Chrissie Thakwalakwa
Address: 
Telephone:
Email:
Affiliation:  University of Malawi
Name:     Kenneth Maleta, MBBS PhD
Address: 
Telephone:
Email:
Affiliation:  University of Malawi
Key inclusion & exclusion criteria

Inclusion Criteria:

- kwashiorkor and/or marasmus

- 6-59 months of age

- lives in local area near enrollment site

Exclusion Criteria:

- recent (<4 months) therapeutic feeding for moderate or severe acute malnutrition

- chronic medical condition (eg, Down syndrome, other congenital syndrome, chronic
heart disease) that may make feeding and growth difficult (not to include HIV or TB)

- caretaker refusal of 2 blood draws

- ineligibility for outpatient therapy (ie, severe illness or anorexia requiring
inpatient therapy)

- caretaker expresses plans to move away from local area of clinic, making followup
difficult



Age minimum: 6 Months
Age maximum: 59 Months
Gender: Both
Health Condition(s) or Problem(s) studied
Kwashiorkor
Marasmus
Intervention(s)
Dietary Supplement: RUTF
Dietary Supplement: RUTF-P
Drug: Amoxicillin
Primary Outcome(s)
EPA Level [Time Frame: 4 weeks]
DHA Level [Time Frame: 4 weeks]
Secondary Outcome(s)
Recovery Rate [Time Frame: 12 weeks]
Ponderal Growth [Time Frame: 12 weeks]
Linear Growth [Time Frame: 12 weeks]
Growth [Time Frame: 12 weeks]
Secondary ID(s)
PUFA-RUTF Pilot
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
University of Malawi
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history